NorthStar will supply non-carrier added Actinium-225, a radionuclide, for use with Ariceum’s first-in-class radiopharmaceutical drug, satoreotide BERLIN and BELOIT, Wis., Dec. 11, 2024 /PRNewswire/ — Ariceum Therapeutics, a private biotech company developing radiopharmaceutical products…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.